Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
208.7 USD | -0.65% | -5.62% | -17.04% |
Apr. 17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
Apr. 12 | Penumbra, Inc. : The underdog in healthcare |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.04% | 8.13B | |
+71.86% | 12.28B | |
+16.56% | 7.31B | |
-4.77% | 5.38B | |
+4.25% | 4.84B | |
+17.19% | 4.23B | |
-21.95% | 4.2B | |
-40.39% | 2.27B | |
+0.50% | 2.03B | |
-5.38% | 1.72B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Penumbra : Earnings Flash (PEN) PENUMBRA Reports Q4 Revenue $166.9M, vs. Street Est of $159.7M